Veralto Corp. is set to report fourth-quarter earnings after Tuesday's market close, with investors watching for signs of sustained growth in water analytics and treatment demand. The report comes amid mixed signals from the broader environmental services sector.
Aerospace and defense supplier TransDigm prepares to release its fourth-quarter results before market open on Tuesday, with analysts anticipating double-digit revenue growth and steady performance in a buoyant sector.
As PayPal prepares to report its fourth-quarter results, investors are watching closely for signs of resilience in its core business and updates on its strategic turnaround efforts. The report could set the tone for the broader fintech sector.
American Financial Group (AFG) is scheduled to release its fourth-quarter earnings after the market closes on Tuesday, with analysts anticipating flat revenue growth. The report comes as the property & casualty insurance sector faces headwinds from policy uncertainty and market volatility.
As Jack Henry & Associates (JKHY) prepares to announce its fiscal fourth-quarter results, the financial technology sector watches closely. The report could set the tone for peers in a market segment recently under pressure.
Graphic Packaging Holding (NYSE:GPK) is scheduled to release its fourth-quarter earnings before Tuesday's market open. Analysts project a year-over-year revenue decline, while investor sentiment in the industrials sector shows cautious optimism.
Japan's manufacturing activity expanded at its fastest pace since mid-2022 in January, a key private survey shows, driven by robust domestic and international orders. While the sector's revival is clear, rising input costs and inflation concerns temper the optimism.
The FDA's Priority Review for Vyvgart's label expansion in myasthenia gravis accelerates Argenx's growth strategy, while investors weigh the company's broader pipeline against its current valuation.
Truist Securities adjusted its price target for American Healthcare REIT (NYSE: AHR) downward slightly, while affirming a Buy rating. The move comes as the firm reassesses its outlook for the broader REIT sector heading into 2026.
Zeta Global Holdings (NYSE: ZETA) is drawing increased attention from Wall Street, with multiple firms raising price targets amid early 2026 momentum. Analysts point to strategic AI partnerships and sector recovery prospects as key drivers.
While the financial sector remains the economy's cornerstone, policy headwinds have capped its recent performance. We analyze one credit rater and a fintech disruptor that show resilience, alongside a legacy asset manager facing challenges.
While the healthcare sector has significantly outperformed the broader market, surging 17.4% in six months, not all companies are positioned to thrive. Intense competition and shifting market dynamics pose risks for some established players. We examine three stocks where investors may want to exercise caution.
While the healthcare sector has surged 17.4% in six months, outpacing the S&P 500, regulatory headwinds and valuation concerns demand a selective approach. We examine one stock with a durable edge and two facing significant challenges.
The financial services sector, a traditional engine of economic growth, is underperforming the S&P 500 amid economic uncertainty. We examine three specific stocks—Invesco, Enova International, and Sixth Street Specialty Lending—that investors may want to approach with heightened caution.
The banking sector has surged 12.5% in six months, outpacing the broader market. Yet, beneath the headline gains, selectivity is key. We analyze one bank with a unique value proposition poised for sustainable growth and flag two others where the risk-reward appears less compelling for investors.
A mixed third-quarter earnings season for therapeutics stocks reveals divergent paths, with United Therapeutics missing estimates while peers like Halozyme and Biogen post strong beats. Sector-wide revenue growth and positive stock reactions suggest underlying investor confidence despite regulatory and pricing headwinds.
The third-quarter earnings season reveals a tale of two strategies in the property services sector. While Opendoor stumbles amid a major strategic shift, peers like Howard Hughes Holdings post surprising strength, highlighting the industry's uneven adaptation to a higher-rate environment.
Regeneron Pharmaceuticals reported a steady finish to 2025, driven by growth in key drugs Dupixent and EYLEA HD. While navigating competitive pressures on its legacy blockbuster, the biotech giant outlined an ambitious 2026 strategy focused on regulatory milestones and a broad clinical pipeline.
Bank of America has increased its price target for industrial packaging firm Greif (GEF) by $1 to $75, while reiterating a Neutral rating. The adjustment follows the bank's broader reassessment of the packaging sector after recent quarterly earnings calls.
Official figures reveal a sharp 26% increase in the annual cost of public sector pensions, now reaching £39bn, with taxpayers covering the bulk of the expense as employer contribution rates rise.
